Keytruda 100 MG/4 ML vial 4ML
Ended Awarded
- Contract number
- SPE2DB25FSY30
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $82,042
Award facts
- Contract value 100% obligated
- $82,041.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order awards DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, a firm fixed-price contract valued at $82,041.50 for the supply of Keytruda 100 mg/4 mL vials. The Defense Logistics Agency, which serves as the funding federal agency, issued this delivery order on May 30, 2025, with an ultimate completion date of June 23, 2025. The contract was awarded without a set-aside designation, allowing DMS Pharmaceutical Group to compete on an unrestricted basis despite its small business status.
This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency's SPE2DB program, a $500 million vehicle valid through November 2026 that enables the issuance of firm fixed-price delivery orders for pharmaceutical products supporting military health facilities worldwide. Keytruda, an oncology medication, represents one of many specialized pharmaceutical products the company supplies through this contract vehicle. DMS Pharmaceutical Group's established role as a critical supplier in the federal pharmaceutical supply chain positions it to fulfill the Department of Defense's ongoing medical supply requirements across its healthcare system.
Quick answers
Who was awarded contract SPE2DB25FSY30?
SPE2DB25FSY30 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on May 30, 2025.
How much is contract SPE2DB25FSY30 worth?
The government has obligated $82,042 on SPE2DB25FSY30.
Is contract SPE2DB25FSY30 an order under another contract?
Yes. SPE2DB25FSY30 is a delivery order under SPE2DB22D9367, an indefinite delivery contract.
Was contract SPE2DB25FSY30 competed?
The extent of competition for SPE2DB25FSY30 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award